After a stellar surge, Fisher & Paykel’s share price is just starting to level off after rising more than 60% in the past year.
According to analysts covering the stock, the high-performing respiratory healthcare company is still trading above many of its valuations and well ahead of its peer
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
